US Patent 8946163 Cross-linked collagen comprising metallic anticancer agents
Patent 8946163 was granted and assigned to MIMEDX GROUP, INC. on February, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 15, 2013
Date of Patent
February 3, 2015
Patent Application Number
13815834
Patent Citations Received
Patent Inventor Names
Thomas J. Koob
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8946163 Cross-linked collagen comprising metallic anticancer agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
